The Association between Type 2 Diabetes Mellitus and Thyroid Cancer. 2017

Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do 14068, Republic of Korea.

OBJECTIVE The incidence of thyroid cancer is increasing worldwide. The prevalence of type 2 diabetes mellitus (T2DM) is also increasing. Therefore, we aimed to analyze the effect of T2DM on thyroid cancer. METHODS A case-control study was performed. A total of 415 healthy controls with thyroid ultrasound screening and physician consultation were selected from the Thyroid Cancer Longitudinal Study (T-CALOS). Among patients with thyroid cancer who were enrolled in T-CALOS, 415 patients were matched to the control group according to age and sex. We assessed the effects of T2DM, T2DM duration, and T2DM medication on thyroid cancer. RESULTS Women with T2DM had lower odds of thyroid cancer than women without T2DM (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.20-0.81). Individuals receiving T2DM medication had higher odds of thyroid cancer compared to those without T2DM medication (OR: 5.21, 95% CI: 1.58-17.15). Individuals with T2DM duration <6 years had lower odds of thyroid cancer compared to those without T2DM (OR: 0.58, 95% CI: 0.34-0.97). CONCLUSIONS Individuals with early T2DM are presumed to have a low incidence of thyroid cancer, and this effect seems to last up to 6 years after diagnosis of T2DM.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
June 2020, Acta clinica Croatica,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
August 2023, Scientific reports,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
January 2024, Frontiers in endocrinology,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
January 2018, Bratislavske lekarske listy,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
January 2018, Medicina,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
January 2019, Diabetes, metabolic syndrome and obesity : targets and therapy,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
January 2020, Journal of Parkinson's disease,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
September 2021, Journal of Nepal Health Research Council,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
March 2012, Yi chuan = Hereditas,
Young-Gyun Seo, and Ho-Chun Choi, and Ah Reum An, and Do Joon Park, and Young Joo Park, and Kyu Eun Lee, and Sue K Park, and Yunji Hwang, and Belong Cho
January 2024, Frontiers in endocrinology,
Copied contents to your clipboard!